Prosensa Announces 3rd Quarter 2014 Financial Results and Recent Corporate Developments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Prosensa Holding N.V. (RNA) Reports Q3 Loss of EUR 0.29/Share
November 17, 2014 7:10 AM ESTProsensa Holding N.V. (NASDAQ: RNA) reported Q3 EPS of (0.29), versus (0.12) reported last year.
Recent Corporate Highlights
Drisapersen Development Program
On September 17, we announced that a staged program of re-dosing had commenced, with the first patients re-dosed in the United States. The re-dosing program in North America will include up to 72 patients across 14 sites... More